colitis and glp-1 drugs calm inflammation beyond diabetes weight loss glp-1 and crohn's disease New

Common nutritional concerns associated with GLP-1 therapy may include: Reduced appetite and inadequate nutrient intake Loss of lean muscle mass during rapid weight reduction Nausea, digestive discomfort, and poor food tolerance Fatigue and reduced energy levels Micronutrient deficiencies over long-term use Increased nutritional needs in patients with complex clinical conditions Effective GLP-1 treatment requires more than medication alone

Find out how to take Rybelsus (semaglutide) correctly

Glucagon-like peptide-1 receptor (GLP-1R) is a versatile therapeutic target that regulates glucose homeostasis, cardiovascular function, neuroprotection, and immune responses

Explore 5 essential takeaways for oncology clinicians regarding the use of GLP-1 receptor agonists in breast cancer management.

Understanding biomarkers, genetic predispositions, and individualized medical evaluation can support informed conversations with providers